Paul Mahon

2020

In 2020, Paul Mahon earned a total compensation of $4.1M as Executive Vice Presidentand General Counsel at United Therapeutics, a 75% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$2,432,869
Non-Equity Incentive Plan$737,880
Salary$908,077
Other$22,400
Total$4,101,226

Mahon received $2.4M of change in pension value and nonqualified deferred compensation earnings, accounting for 59% of the total pay in 2020.

Mahon also received $737.9K in non-equity incentive plan, $908.1K in salary and $22.4K in other compensation.

Rankings

In 2020, Paul Mahon's compensation ranked 2,771st out of 13,090 executives tracked by ExecPay. In other words, Mahon earned more than 78.8% of executives.

ClassificationRankingPercentile
All
2,771
out of 13,090
79th
Division
Manufacturing
1,060
out of 5,618
81st
Major group
Chemicals And Allied Products
394
out of 2,251
83rd
Industry group
Drugs
340
out of 1,951
83rd
Industry
Pharmaceutical Preparations
247
out of 1,456
83rd
Source: SEC filing on April 29, 2022.

Mahon's colleagues

We found three more compensation records of executives who worked with Paul Mahon at United Therapeutics in 2020.

2020

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2020

Martine Rothblatt

United Therapeutics

Chief Executive Officer

2020

James Edgemond

United Therapeutics

Chief Financial Officer

News

You may also like